The role of CEBPα mutations in the progression of myeloid leukemias.

被引：0
|
作者：
Shih, LY
Huang, CF
Liang, DC
Lin, TL
Wu, JH
Wang, PN
Dunn, P
Kuo, MC
Tang, CC
机构：
[1] Chang Gung Mem Hosp, Div Hematol Oncol, Taipei, Taiwan
[2] Chang Gung Univ, Sch Med, Taipei, Taiwan
[3] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3004
引用
收藏
页码：821A / 821A
页数：1
相关论文
共 50 条
  • [21] The transcription factor C/EBPα is mutated in myelodysplastic syndromes and acute myeloid leukemias.
    Gombart, AF
    Hofmann, WK
    Kawano, S
    Takeuchi, S
    Krug, U
    Kwok, SH
    Larson, R
    Asou, H
    Miller, CW
    Hoelzer, DF
    Koeffler, HP
    BLOOD, 2001, 98 (11) : 95A - 95A
  • [22] Plasma gelatinolytic activity in leukemias.
    Wrzyszcz, A
    Urbaniak, J
    Wrobel, T
    Mazur, G
    Tomaszewska-Toporska, B
    Kuliczkowski, K
    Wozniak, M
    BLOOD, 2004, 104 (11) : 42B - 42B
  • [23] The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. European group for the immunological classification of Leukemias (EGIL).
    Bene, MC
    Bernier, M
    Castoldi, G
    Knapp, W
    Ludwig, WD
    Matutes, E
    Orfao, A
    vantVeer, MB
    BLOOD, 1997, 90 (10) : 2226 - 2226
  • [24] N-RAS MUTATIONS IN MYELOID LEUKEMIAS
    SAGLIO, G
    SERRA, A
    NOVARINO, A
    FALDA, M
    GAVOSTO, F
    TUMORI, 1989, 75 (04) : 337 - 340
  • [25] Tumor markers in lymphomas and leukemias.
    Wasik, M
    CLINICAL CHEMISTRY, 1999, 45 (06) : S30 - S30
  • [26] Impaired expression of the DNA repair factor DDB2 in human myeloid leukemias.
    Takimoto, R
    Kato, J
    Takada, K
    Kuroiwa, G
    Niitsu, Y
    BLOOD, 2002, 100 (11) : 198B - 198B
  • [27] Impaired expression of the DNA repair factor DDB2 in human myeloid leukemias.
    Takimoto, R
    Kato, J
    Takada, K
    Matsunaga, T
    Niitsu, Y
    BLOOD, 2004, 104 (11) : 564A - 564A
  • [28] Concurrent inflammatory bowel disease and the leukemias.
    Harewood, GC
    Loftus, EV
    Sandborn, WJ
    Tremaine, WJ
    GASTROENTEROLOGY, 1998, 114 (04) : A992 - A992
  • [29] Effects of in vivo administration of interleukin-4 (IL-4) to patients with myeloid leukemias.
    Venugopal, P
    Raza, A
    Jajeh, A
    Gregory, SA
    Gezer, S
    Cloutier, D
    Chopra, HK
    Mundle, S
    Sivaraman, S
    Yang, J
    Preisler, HD
    BLOOD, 1997, 90 (10) : 3856 - 3856
  • [30] Interleukin-10 plasma levels are frequently elevated in MDS and acute and chronic myeloid leukemias.
    Kliche, KO
    Sarris, AH
    Estey, E
    Snell, V
    Andreeff, M
    BLOOD, 1997, 90 (10) : 4044 - 4044
12345